Kombiglyze
Pajjiż: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Metformin hydrochloride 500mg; ; Saxagliptin 2.5mg
Disponibbli minn:
AstraZeneca Limited
INN (Isem Internazzjonali):
Metformin hydrochloride 500 mg
Dożaġġ:
2.5mg/500mg
Għamla farmaċewtika:
Film coated tablet
Kompożizzjoni:
Active: Metformin hydrochloride 500mg Saxagliptin 2.5mg Excipient: Hydrochloric acid Magnesium stearate Opacode blue S-1-10619 Opadry pink 85F14452 Opadry white 85F18422 Povidone Purified water
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Merck Sante SAS
Indikazzjonijiet terapewtiċi:
Kombiglyze is indicated as an adjunct to diet & exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin & metformin is appropriate.
Sommarju tal-prodott:
Package - Contents - Shelf Life: Blister pack, - 56 tablets - 2 years from date of manufacture stored at or below 25°C
Data ta 'l-awtorizzazzjoni:
2013-12-12
